Europe — EMA

Osaver (Olmesartan Medoxomil)

Olmesartan Medoxomil, the active ingredient in Osaver, is an Angiotensin II receptor blocker (ARB) presented as a oral tablet for systemic use.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan Medoxomil, the active ingredient in Osaver, is an Angiotensin II receptor blocker (ARB) presented as a oral tablet for systemic use. It treats hypertension and is prescribed for adults who need blood pressure control.

GNH USA supplies Osaver as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Osaver is an ARB that lowers blood pressure by acting on the renin‑angiotensin system. - Hypertension: helps achieve target blood pressure and reduces cardiovascular risk. - Heart failure: used as part of combination therapy to improve symptoms and outcomes. - Diabetic nephropathy: slows progression of kidney damage associated with diabetes.

What are the side effects of Olmesartan Medoxomil?

Side effects can vary across patients and … t t

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →